Cargando…

Plasma biomarkers inclusive of α-synuclein/amyloid-beta40 ratio strongly correlate with Mini-Mental State Examination score in Parkinson’s disease and predict cognitive impairment

Plasma biomarkers for Parkinson’s disease (PD) diagnosis that carry predictive value for cognitive impairment are valuable. We explored the relationship of Mini-Mental State Examination (MMSE) score with plasma biomarkers in PD patients and compared results to vascular dementia (VaD) and normal cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Daniel Kam Yin, Chen, Jack, Chen, Ren Fen, Parikh, Jayesh, Xu, Ying Hua, Silburn, Peter A., Mellick, George D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618522/ https://www.ncbi.nlm.nih.gov/pubmed/35879562 http://dx.doi.org/10.1007/s00415-022-11287-5

Ejemplares similares

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease
por: Chan, Daniel Kam Yin, et al.
Publicado: (2017)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
por: Han, Jiajun, et al.
Publicado: (2021)

Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
por: Verberk, Inge M. W., et al.
Publicado: (2020)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
por: Köppen, Janett, et al.
Publicado: (2020)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease
por: Smith, Jessica K., et al.
Publicado: (2023)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
por: Poortvliet, Peter Cornelis, et al.
Publicado: (2021)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein
por: Phelan, M. M., et al.
Publicado: (2017)

Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases
por: Albus, Alexandra, et al.
Publicado: (2019)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Perspective: Current Pitfalls in the Search for Future Treatments and Prevention of Parkinson's Disease
por: Poortvliet, Peter C., et al.
Publicado: (2020)

Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates
por: Anderson, Valerie L, et al.
Publicado: (2011)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease
por: Sheard, Jamie M., et al.
Publicado: (2013)

A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
por: Al- Ayadhi, Laila Y, et al.
Publicado: (2012)

Malnutrition in a Sample of Community-Dwelling People with Parkinson’s Disease
por: Sheard, Jamie M., et al.
Publicado: (2013)

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan
por: Khan, Suliman, et al.
Publicado: (2016)

Role of Tyr-39 for the Structural Features of α-Synuclein and for the Interaction with a Strong Modulator of Its Amyloid Assembly
por: Palomino-Hernandez, Oscar, et al.
Publicado: (2020)

Improved nutritional status is related to improved quality of life in Parkinson’s disease
por: Sheard, Jamie M, et al.
Publicado: (2014)

Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
por: Kim, Tae-Eun, et al.
Publicado: (2021)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
por: Raiss, Christian C., et al.
Publicado: (2016)

In situ architecture of neuronal α-Synuclein inclusions
por: Trinkaus, Victoria A., et al.
Publicado: (2021)

Alpha-Synuclein Inclusion Formation in Human Oligodendrocytes
por: Yoon, Ye-Seul, et al.
Publicado: (2021)

α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
por: Falke, Marcel, et al.
Publicado: (2019)

A Rare Case of Green Gelatinous Mass Formation on a Deep Brain Stimulation Implantable Pulse Generator
por: Poortvliet, Peter C., et al.
Publicado: (2021)

Mini betas at DESY
Publicado: (1981)

Synthetic Fragments of Receptor for Advanced Glycation End Products Bind Beta-Amyloid 1–40 and Protect Primary Brain Cells From Beta-Amyloid Toxicity
por: Kamynina, Anna V., et al.
Publicado: (2018)

Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease
por: Tenreiro, Sandra, et al.
Publicado: (2014)

TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
por: Bender, Andreas, et al.
Publicado: (2013)

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease
por: Fernández-Espejo, Emilio, et al.
Publicado: (2021)

Mini review: linkage between α-Synuclein protein and cognition
por: Saleh, Huda, et al.
Publicado: (2015)

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
por: Chen, Nai-Ching, et al.
Publicado: (2020)

Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
por: Araki, Katsuya, et al.
Publicado: (2019)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021)

Mini Review: Correlations of Cognitive Domains With Cerebrospinal Fluid α-Synuclein Levels in Patients With Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kfav76abg7mmu90v0gb6skqt5c